Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q6ZWT7

Entry ID Method Resolution Chain Position Source
AF-Q6ZWT7-F1 Predicted AlphaFoldDB

300 variants for Q6ZWT7

Variant ID(s) Position Change Description Diseaes Association Provenance
CA345869861
rs1421696008
2 A>V No ClinGen
TOPMed
rs1479029193
CA345869840
6 T>A No ClinGen
TOPMed
CA345869831
rs1301742146
7 T>K No ClinGen
gnomAD
CA42403661
rs918042095
12 L>M No ClinGen
TOPMed
rs897661702
CA42403658
16 S>I No ClinGen
Ensembl
CA345869764
rs1573305700
18 A>S No ClinGen
Ensembl
CA345869752
rs1383027867
20 Q>* No ClinGen
gnomAD
CA345869733
rs1322874558
23 I>V No ClinGen
gnomAD
TCGA novel 27 N>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs767103005
CA1520982
27 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA345869678
rs1404705372
29 V>I No ClinGen
gnomAD
CA1520981
rs183371237
30 V>A No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA345869640
rs1573169338
34 F>C No ClinGen
Ensembl
CA345869616
rs766262429
38 A>G No ClinGen
ExAC
gnomAD
rs766262429
CA1520979
38 A>V No ClinGen
ExAC
gnomAD
CA345869610
rs1391064421
39 A>G No ClinGen
gnomAD
CA345869607
rs1224836305
40 I>V No ClinGen
TOPMed
CA345869595
rs1328478095
41 W>* No ClinGen
TOPMed
rs1283836262
CA345869596
41 W>L No ClinGen
TOPMed
CA1520978
rs762776291
COSM1690186
43 R>* skin [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
CA345869581
rs1471364240
43 R>L No ClinGen
TOPMed
gnomAD
CA345869583
rs1471364240
COSM173878
43 R>Q Variant assessed as Somatic; 0.0 impact. large_intestine endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
gnomAD
rs773061447
COSM1409932
CA1520977
44 T>I Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
TCGA novel 46 L>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA1520975
rs761829337
50 K>N No ClinGen
ExAC
gnomAD
TCGA novel 51 T>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs142344615
CA1520974
51 T>S No ClinGen
ESP
ExAC
TOPMed
CA1520973
rs772211309
52 S>G No ClinGen
ExAC
gnomAD
CA345869460
rs1452378930
62 L>V No ClinGen
gnomAD
CA42376250
rs1050788947
65 L>F No ClinGen
TOPMed
rs1331382673
CA345869427
67 L>F No ClinGen
gnomAD
rs996102525
CA42376245
68 A>S No ClinGen
TOPMed
rs1385564922
CA345869177
76 A>T No ClinGen
gnomAD
rs766059198
CA1520961
76 A>V No ClinGen
ExAC
gnomAD
CA345869142
rs750132753
81 V>I No ClinGen
ExAC
TOPMed
gnomAD
CA345869143
CA1520959
rs750132753
81 V>L No ClinGen
ExAC
TOPMed
gnomAD
rs765124323
CA1520958
83 S>N No ClinGen
ExAC
gnomAD
rs1296335320
CA345869092
88 C>S No ClinGen
gnomAD
CA345869056
rs1432487426
93 I>V No ClinGen
TOPMed
gnomAD
CA1520953
rs774447645
98 M>I No ClinGen
ExAC
gnomAD
rs759547712
CA1520954
98 M>V No ClinGen
ExAC
gnomAD
CA1520952
rs771093333
99 H>P No ClinGen
ExAC
gnomAD
rs573728551
CA1520950
100 N>D No ClinGen
1000Genomes
ExAC
gnomAD
rs1448699593
CA345868959
104 V>L No ClinGen
gnomAD
rs763981241
CA345868941
107 L>V No ClinGen
ExAC
TOPMed
gnomAD
rs930214033
CA42334257
108 G>V No ClinGen
TOPMed
gnomAD
CA345868910
rs1178566481
112 V>L No ClinGen
TOPMed
CA345868896
rs1359949476
114 Q>E No ClinGen
TOPMed
rs766486740
CA1520935
115 V>I No ClinGen
ExAC
TOPMed
gnomAD
rs1270536778
CA345868883
116 T>S No ClinGen
Ensembl
rs773540303
CA1520933
117 R>* No ClinGen
ExAC
TOPMed
gnomAD
CA345868859
rs1401088204
120 I>V No ClinGen
TOPMed
TCGA novel 122 D>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA42334202
rs992974796
122 D>V No ClinGen
TOPMed
rs376404172
CA1520932
123 Y>C No ClinGen
ESP
ExAC
gnomAD
TCGA novel 124 G>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs777109849
CA1520912
133 P>L No ClinGen
ExAC
gnomAD
rs777109849
CA345773004
133 P>R No ClinGen
ExAC
gnomAD
CA1520911
rs769179279
134 M>T No ClinGen
ExAC
gnomAD
rs1266910856
CA345772999
134 M>V No ClinGen
gnomAD
CA345772899
rs1266100719
141 I>T No ClinGen
gnomAD
CA345772881
rs1383159402
143 S>G No ClinGen
gnomAD
rs887184796
CA42371442
143 S>N No ClinGen
TOPMed
CA1520909
rs776086490
145 A>S No ClinGen
ExAC
gnomAD
rs80260344
CA1520908
146 C>F No ClinGen
ExAC
gnomAD
CA42371413
rs955335450
COSM276015
147 E>K lung large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
Ensembl
NCI-TCGA
CA1520906
rs778309710
148 I>N No ClinGen
ExAC
rs762953930
CA1520905
149 H>R No ClinGen
ExAC
gnomAD
CA1520904
rs748981866
150 D>A No ClinGen
ExAC
rs769441197
CA1520884
152 M>L No ClinGen
ExAC
gnomAD
rs769441197
CA345772060
152 M>V No ClinGen
ExAC
gnomAD
rs886764874
CA42366697
153 F>C No ClinGen
TOPMed
CA345772045
rs780868284
154 R>P No ClinGen
ExAC
TOPMed
gnomAD
CA1520882
rs780868284
154 R>Q No ClinGen
ExAC
TOPMed
gnomAD
rs542141791
CA1520883
154 R>W No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs898759003
CA42366684
155 K>N No ClinGen
Ensembl
rs1189930692
CA345772004
160 T>N No ClinGen
gnomAD
rs1189930692
CA345772003
160 T>S No ClinGen
gnomAD
rs751489034
CA1520880
161 S>F No ClinGen
ExAC
gnomAD
rs1255310723
CA345771991
162 S>L No ClinGen
gnomAD
CA345771964
rs1484089150
166 L>S No ClinGen
gnomAD
TCGA novel 169 R>= Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs756373257
CA1520856
COSM1752722
170 R>C urinary_tract [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
rs767912767
CA1520854
170 R>H No ClinGen
ExAC
TOPMed
gnomAD
rs767912767
CA345771122
170 R>L No ClinGen
ExAC
TOPMed
gnomAD
rs767912767
CA1520855
170 R>P No ClinGen
ExAC
TOPMed
gnomAD
rs1572942641
CA345771093
173 S>G No ClinGen
Ensembl
CA1520852
rs751980590
173 S>N No ClinGen
ExAC
TOPMed
gnomAD
rs375049894
CA345771045
176 E>D No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs139247880
CA1520850
177 Y>C No ClinGen
1000Genomes
ExAC
gnomAD
CA345770958
rs1345764386
181 N>H No ClinGen
gnomAD
rs764762344
CA1520848
185 M>V No ClinGen
ExAC
gnomAD
rs149971409
CA1520847
187 I>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1282610321
CA345770763
191 P>S No ClinGen
TOPMed
rs1483613032
CA345770678
196 K>E No ClinGen
TOPMed
CA42362233
rs987433418
199 I>M No ClinGen
Ensembl
CA345770598
rs1407741208
199 I>S No ClinGen
gnomAD
CA345770608
rs1558562999
199 I>V No ClinGen
Ensembl
rs768362605
CA1520845
200 T>I No ClinGen
ExAC
rs775452718
CA1520843
205 R>G No ClinGen
ExAC
gnomAD
rs1430758667
CA345770517
205 R>S No ClinGen
TOPMed
CA1520842
rs370566703
208 H>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs745842248
CA1520841
209 I>V No ClinGen
ExAC
gnomAD
rs777996869
CA1520840
212 S>P No ClinGen
ExAC
gnomAD
rs756322066
CA1520839
213 G>C No ClinGen
ExAC
gnomAD
CA1520838
rs748274292
214 E>D Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA1520837
rs374881990
219 E>Q No ClinGen
ESP
ExAC
gnomAD
CA1520835
rs146137070
222 Y>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA345770219
rs1414149743
223 E>K No ClinGen
gnomAD
rs1158930325
CA345770188
225 T>A No ClinGen
gnomAD
rs1466100098
CA345770170
226 E>V No ClinGen
TOPMed
TCGA novel 228 S>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA345770149
rs1477606020
229 P>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA1520817
rs747291673
231 T>A No ClinGen
ExAC
rs935685993
CA42359575
COSM282701
232 A>V Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
gnomAD
CA1520815
rs34573615
233 V>I No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA345770103
rs1572934220
235 Q>E No ClinGen
Ensembl
CA1520813
rs138674759
235 Q>R No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA345770077
rs757808251
238 L>F No ClinGen
ExAC
gnomAD
rs933772053
CA42359509
240 C>R No ClinGen
TOPMed
CA42359504
rs943818831
244 L>F No ClinGen
Ensembl
CA1520809
rs760240347
248 L>W No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 250 I>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs752456279
CA1520808
250 I>V No ClinGen
ExAC
gnomAD
CA345769999
rs1363454249
251 C>S No ClinGen
gnomAD
CA1520807
rs767292641
254 L>S No ClinGen
ExAC
gnomAD
CA1520806
rs759339947
257 E>G No ClinGen
ExAC
gnomAD
rs1370170719
CA345769934
260 I>T No ClinGen
gnomAD
rs774317615
CA1520805
263 H>N No ClinGen
ExAC
gnomAD
rs1420346617
CA345769895
265 Q>R No ClinGen
gnomAD
TCGA novel 266 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA345769883
rs1181408333
267 T>S No ClinGen
gnomAD
CA345769877
rs1279626680
268 A>D No ClinGen
TOPMed
CA1520804
rs770723802
268 A>T No ClinGen
ExAC
gnomAD
COSM3714318
rs1036871251
CA42359442
269 S>L upper_aerodigestive_tract [Cosmic] No ClinGen
cosmic curated
TOPMed
gnomAD
rs762996415
CA1520803
271 P>T No ClinGen
ExAC
gnomAD
CA1520802
rs202062819
272 T>A No ClinGen
ExAC
TOPMed
gnomAD
rs768843029
CA1520801
274 I>V No ClinGen
ExAC
TOPMed
gnomAD
rs1295645885
CA345769829
275 I>M No ClinGen
gnomAD
CA345769831
rs1308694066
275 I>T No ClinGen
gnomAD
CA42359394
rs909838545
278 Y>C No ClinGen
TOPMed
gnomAD
TCGA novel 281 L>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA1520797
rs772283165
283 A>S No ClinGen
ExAC
TOPMed
gnomAD
CA42359379
rs959389480
284 A>P No ClinGen
TOPMed
gnomAD
rs959389480
CA345769728
284 A>T No ClinGen
TOPMed
gnomAD
CA345769663
rs1355379840
288 Y>* No ClinGen
gnomAD
rs1463702398
CA345769673
288 Y>N No ClinGen
gnomAD
CA1520795
rs779386481
293 T>M No ClinGen
ExAC
TOPMed
gnomAD
rs756721934
CA1520771
299 N>Y No ClinGen
ExAC
gnomAD
rs1001222633
CA42355528
300 N>S No ClinGen
gnomAD
CA1520770
rs747611257
303 G>A No ClinGen
ExAC
gnomAD
rs1434549608
CA345768774
307 R>G No ClinGen
gnomAD
CA1520769
rs780896584
309 Y>C No ClinGen
ExAC
gnomAD
CA345768749
rs1387071211
309 Y>H No ClinGen
gnomAD
TCGA novel 310 D>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA1520766
rs555195886
311 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
CA42355481
rs994204301
313 G>E No ClinGen
Ensembl
CA1520765
rs758151598
314 A>V No ClinGen
ExAC
gnomAD
CA1520764
rs750186080
316 R>C No ClinGen
ExAC
TOPMed
gnomAD
CA1520762
rs764306370
316 R>H No ClinGen
ExAC
TOPMed
gnomAD
CA1520763
rs764306370
316 R>L No ClinGen
ExAC
TOPMed
gnomAD
CA345768576
rs1558552993
321 S>P No ClinGen
Ensembl
CA345768497
rs1259496946
327 Q>E No ClinGen
gnomAD
rs775520528
CA1520761
329 E>G No ClinGen
ExAC
gnomAD
TCGA novel 329 E>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA42351805
rs1036127335
330 M>I No ClinGen
TOPMed
gnomAD
CA1520735
rs535727689
332 T>A No ClinGen
1000Genomes
ExAC
gnomAD
rs753835262
CA1520734
332 T>I No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 333 S>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs764032416
CA1520733
335 K>R No ClinGen
ExAC
gnomAD
CA1520732
rs187474422
336 M>K No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA345767501
rs187474422
336 M>T No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1185719727
CA345767441
339 D>G No ClinGen
gnomAD
CA345767448
rs1237633861
339 D>N No ClinGen
TOPMed
CA1520730
rs766577470
343 I>S No ClinGen
ExAC
gnomAD
rs1181236164
CA345767338
344 Q>R No ClinGen
gnomAD
rs1287898993
CA345767311
345 T>I No ClinGen
TOPMed
rs150340101
CA1520704
352 V>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1454776174
CA345766613
354 Y>C No ClinGen
TOPMed
gnomAD
rs893319735
CA42350177
355 E>D No ClinGen
TOPMed
gnomAD
CA42350171
rs140299461
356 R>* No ClinGen
ESP
gnomAD
CA42350158
rs7602744
356 R>Q No ClinGen
gnomAD
CA42350151
rs779729146
357 T>N No ClinGen
gnomAD
rs374729581
CA1520702
362 T>A No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs374729581
CA42350146
362 T>P No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs770604969
CA1520701
364 Q>H No ClinGen
ExAC
gnomAD
rs749037038
CA1520700
365 T>M No ClinGen
ExAC
gnomAD
CA345766525
rs1269471153
368 L>F No ClinGen
gnomAD
CA1520695
rs755930105
371 I>V No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 372 W>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs202137034
CA42350084
374 G>R No ClinGen
Ensembl
TCGA novel 378 G>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 379 Y>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA1520693
rs765515703
380 Y>H No ClinGen
ExAC
gnomAD
rs1175766245
CA345766413
385 T>I No ClinGen
gnomAD
rs371168348
CA42350020
CA1520689
387 V>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs371168348
CA345766404
387 V>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA345766389
rs1264934923
389 M>T No ClinGen
TOPMed
CA1520688
rs761232552
391 L>* No ClinGen
ExAC
gnomAD
CA1520687
rs377425211
392 A>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA42349990
rs913159299
393 A>G No ClinGen
Ensembl
CA1520686
rs768074188
393 A>T No ClinGen
ExAC
gnomAD
TCGA novel 394 R>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 399 N>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs769487017
CA1520659
400 F>I No ClinGen
ExAC
gnomAD
CA345766292
rs1403808594
402 H>N No ClinGen
TOPMed
rs901167253
CA42348162
402 H>R No ClinGen
TOPMed
CA1520658
rs747857607
403 Y>D No ClinGen
ExAC
TOPMed
gnomAD
CA345766251
rs1274989492
404 F>L No ClinGen
gnomAD
rs1558543387
CA345766220
407 P>T No ClinGen
Ensembl
CA1520657
rs776506086
408 S>C No ClinGen
ExAC
gnomAD
CA1520656
rs371335603
409 Q>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA345766164
rs146795028
411 K>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs146795028
CA1520655
411 K>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 413 F>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1232812855
CA345766091
415 D>G No ClinGen
TOPMed
rs1282556293
CA345766067
417 I>M Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA345766005
rs1374380000
420 I>T No ClinGen
gnomAD
rs779124430
CA1520654
420 I>V No ClinGen
ExAC
gnomAD
TCGA novel 421 V>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs757355387
CA1520653
423 Q>E No ClinGen
ExAC
gnomAD
CA345765955
rs561333784
423 Q>H No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA1520651
rs376215272
426 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 432 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 437 S>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs982755029
CA42348088
440 P>A No ClinGen
TOPMed
gnomAD
rs143839710
CA1520648
442 L>F No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs143839710
CA345765656
442 L>I No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA1520647
rs139368884
443 T>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs996647128
CA42348059
444 F>V No ClinGen
Ensembl
CA1520645
rs766881306
446 S>G No ClinGen
ExAC
gnomAD
rs780495167
CA1520625
446 S>R No ClinGen
ExAC
gnomAD
CA345765576
rs766881306
446 S>R No ClinGen
ExAC
gnomAD
CA345764857
rs1350389046
448 W>* No ClinGen
gnomAD
CA345764850
rs1572899219
448 W>C No ClinGen
Ensembl
CA345764793
rs1304961489
451 C>F No ClinGen
TOPMed
gnomAD
rs1256633766
CA345764802
451 C>R No ClinGen
gnomAD
rs1226877825
CA345764771
453 H>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA1520624
rs150735455
454 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1033482064
CA42346154
455 L>V No ClinGen
Ensembl
CA345764672
rs1383087390
458 L>F No ClinGen
gnomAD
rs749877859
CA1520623
458 L>V No ClinGen
ExAC
gnomAD
rs1458494185
CA345764651
460 L>V No ClinGen
TOPMed
gnomAD
rs199729641
CA1520622
461 L>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs138658930
CA1520621
464 P>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA1520620
rs753475039
465 V>A No ClinGen
ExAC
TOPMed
gnomAD
rs1376965890
CA345764555
466 K>E No ClinGen
gnomAD
rs1558541367
CA345764521
467 K>R No ClinGen
Ensembl
rs201954366
CA1520617
468 T>A No ClinGen
1000Genomes
ExAC
gnomAD
rs962806227 468 T>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
rs1558541331
CA345764504
468 T>N No ClinGen
Ensembl
CA345764491
rs1172489685
469 Q>P No ClinGen
gnomAD
rs1256517489
CA345764461
471 R>G No ClinGen
gnomAD
TCGA novel 472 K>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA345764430
rs1486775223
472 K>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA345764404
rs1424859249
474 T>I No ClinGen
gnomAD
CA1520615
rs759562992
475 H>R No ClinGen
ExAC
gnomAD
rs528858533
CA42346076
475 H>Y No ClinGen
gnomAD
rs1047514599
CA42346057
476 E>K No ClinGen
Ensembl
CA345764349
rs1558541249
477 N>K No ClinGen
Ensembl
rs1253547278
CA345764274
482 Q>* No ClinGen
gnomAD
CA345764235
rs1219756001
484 K>E No ClinGen
TOPMed
gnomAD
CA42346052
rs138609923
484 K>R No ClinGen
ESP
TOPMed
TCGA novel 484 K>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs372386739
CA1520614
486 F>Y No ClinGen
ESP
ExAC
gnomAD
rs1426532743
CA345764162
487 D>E No ClinGen
TOPMed
rs140635509
CA1520613
487 D>V No ClinGen
ESP
ExAC
gnomAD
rs748187209
CA1520612
488 E>K No ClinGen
ExAC
gnomAD
TCGA novel 489 G>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs146784263
CA1520610
489 G>E No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs781320747
CA1520611
489 G>R No ClinGen
ExAC
gnomAD
TCGA novel 490 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA42346020
rs201263458
491 N>S No ClinGen
gnomAD
CA345764089
rs1466050709
492 S>Y Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs148555544
CA1520608
493 L>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA1520606
rs746452770
494 G>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA1520605
rs369922486
495 Q>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1191224515
CA345763984
497 S>T No ClinGen
gnomAD
CA1520604
rs756721748
498 F>C No ClinGen
ExAC
gnomAD
rs1381965128
CA345763932
500 T>A No ClinGen
TOPMed
rs16866827
CA1520603
VAR_030068
501 T>A No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs755883588
CA1520601
502 N>K No ClinGen
ExAC
gnomAD
rs763791764
CA1520602
502 N>S No ClinGen
ExAC
gnomAD
CA345763873
rs1273987581
503 N>D No ClinGen
TOPMed
rs1340168000
CA345763869
503 N>S No ClinGen
TOPMed
rs1572898612
CA345763841
505 C>Y No ClinGen
Ensembl
rs143390233
CA1520597
506 N>I No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs143390233
CA1520596
506 N>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs112413155
CA42345945
507 Q>* No ClinGen
TOPMed
gnomAD
TCGA novel 510 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA1520595
rs184069582
511 I>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs574002894
CA1520594
513 S>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA345763688
rs1558540966
513 S>P No ClinGen
Ensembl
CA1520593
rs574002894
513 S>W No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA1520591
rs749156955
514 R>K No ClinGen
ExAC
TOPMed
gnomAD
CA1520590
rs747272456
515 H>Y No ClinGen
ExAC
TOPMed
gnomAD
rs1393567651
CA345763630
517 S>A No ClinGen
gnomAD
CA345763593
rs1323813442
519 K>T No ClinGen
gnomAD
CA42345880
rs201166810
520 Q>H No ClinGen
gnomAD
CA1520589
rs775578013
521 Q>G No ClinGen
ExAC
TOPMed
gnomAD

1 associated diseases with Q6ZWT7

[MIM: 613625]: Factor V and factor VIII combined deficiency 2 (F5F8D2)

A blood coagulation disorder characterized by bleeding symptoms similar to those in hemophilia or parahemophilia, that are caused by single deficiency of FV or FVIII, respectively. The most common symptoms are epistaxis, menorrhagia, and excessive bleeding during or after trauma. Plasma levels of coagulation factors V and VIII are in the range of 5 to 30% of normal. {ECO:0000269|PubMed:12717434, ECO:0000269|PubMed:18590741, ECO:0000269|PubMed:18685427, ECO:0000269|PubMed:20491958}. Note=The disease is caused by variants affecting the gene represented in this entry.

Without disease ID
  • A blood coagulation disorder characterized by bleeding symptoms similar to those in hemophilia or parahemophilia, that are caused by single deficiency of FV or FVIII, respectively. The most common symptoms are epistaxis, menorrhagia, and excessive bleeding during or after trauma. Plasma levels of coagulation factors V and VIII are in the range of 5 to 30% of normal. {ECO:0000269|PubMed:12717434, ECO:0000269|PubMed:18590741, ECO:0000269|PubMed:18685427, ECO:0000269|PubMed:20491958}. Note=The disease is caused by variants affecting the gene represented in this entry.

1 regional properties for Q6ZWT7

Type Name Position InterPro Accession
domain Synaptotagmin-like mitochondrial-lipid-binding domain 1 - 195 IPR031468

Functions

Description
EC Number 2.3.1.23 Transferring groups other than amino-acyl groups
Subcellular Localization
  • Membrane ; Multi-pass membrane protein
  • Endoplasmic reticulum
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
endoplasmic reticulum membrane The lipid bilayer surrounding the endoplasmic reticulum.
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
membrane A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.

6 GO annotations of molecular function

Name Definition
1-acylglycerol-3-phosphate O-acyltransferase activity Catalysis of the reaction: acyl-CoA + 1-acyl-sn-glycerol-3-phosphate = CoA + 1,2-diacyl-sn-glycerol-3-phosphate.
1-acylglycerophosphocholine O-acyltransferase activity Catalysis of the reaction: 1-acyl-sn-glycero-3-phosphocholine + acyl-CoA = phosphatidylcholine + CoA.
1-acylglycerophosphoethanolamine O-acyltransferase activity Catalysis of the reaction: a 1-acyl-sn-glycero-3-phosphoethanolamine + an acyl-CoA = a 1,2-diacyl-sn-glycero-3-phosphoethanolamine + CoA.
1-acylglycerophosphoserine O-acyltransferase activity Catalysis of the reaction:a 1-acyl-sn-glycero-3-phospho-L-serine + an acyl-CoA = a 1,2-diacyl-sn-glycero-3-phospho-L-serine + CoA.
2-acylglycerol-3-phosphate O-acyltransferase activity Catalysis of the reaction: 2-acyl-sn-glycerol 3-phosphate + acyl-CoA = L-phosphatidate + CoA.
acyltransferase activity Catalysis of the transfer of an acyl group from one compound (donor) to another (acceptor).

6 GO annotations of biological process

Name Definition
lipid modification The covalent alteration of one or more fatty acids in a lipid, resulting in a change in the properties of the lipid.
phosphatidylcholine acyl-chain remodeling Remodeling the acyl chains of phosphatidylcholine, through sequential deacylation and re-acylation reactions, to generate phosphatidylcholine containing different types of fatty acid acyl chains.
phosphatidylethanolamine acyl-chain remodeling Remodeling the acyl chains of phosphatidylethanolamine, through sequential deacylation and re-acylation reactions, to generate phosphatidylethanolamine containing different types of fatty acid acyl chains.
phosphatidylserine acyl-chain remodeling Remodeling the acyl chains of phosphatidylserine, through sequential deacylation and re-acylation reactions, to generate phosphatidylserine containing different types of fatty acid acyl chains.
phospholipid biosynthetic process The chemical reactions and pathways resulting in the formation of a phospholipid, a lipid containing phosphoric acid as a mono- or diester.
regulation of chondrocyte differentiation Any process that modulates the frequency, rate or extent of chondrocyte differentiation.

1 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q6ZNC8 MBOAT1 Lysophospholipid acyltransferase 1 Homo sapiens (Human) PR
10 20 30 40 50 60
MATTSTTGST LLQPLSNAVQ LPIDQVNFVV CQLFALLAAI WFRTYLHSSK TSSFIRHVVA
70 80 90 100 110 120
TLLGLYLALF CFGWYALHFL VQSGISYCIM IIIGVENMHN YCFVFALGYL TVCQVTRVYI
130 140 150 160 170 180
FDYGQYSADF SGPMMIITQK ITSLACEIHD GMFRKDEELT SSQRDLAVRR MPSLLEYLSY
190 200 210 220 230 240
NCNFMGILAG PLCSYKDYIT FIEGRSYHIT QSGENGKEET QYERTEPSPN TAVVQKLLVC
250 260 270 280 290 300
GLSLLFHLTI CTTLPVEYNI DEHFQATASW PTKIIYLYIS LLAARPKYYF AWTLADAINN
310 320 330 340 350 360
AAGFGFRGYD ENGAARWDLI SNLRIQQIEM STSFKMFLDN WNIQTALWLK RVCYERTSFS
370 380 390 400 410 420
PTIQTFILSA IWHGVYPGYY LTFLTGVLMT LAARAMRNNF RHYFIEPSQL KLFYDVITWI
430 440 450 460 470 480
VTQVAISYTV VPFVLLSIKP SLTFYSSWYY CLHILGILVL LLLPVKKTQR RKNTHENIQL
490 500 510
SQSKKFDEGE NSLGQNSFST TNNVCNQNQE IASRHSSLKQ